Clinical, microbiological, and genetic characteristics of heteroresistant vancomycin-intermediate staphylococcus aureus Bacteremia in a Teaching Hospital

Microbial Drug Resistance

Volumn 21, Issue 1, 2015, Pages 25-34

  Di Gregorio, Sabrina ^a   Perazzi, Beatriz ^b   Ordoñez, Andrea Martinez ^b   De Gregorio, Stella ^b   Foccoli, Monica ^b   Lasala, María Beatriz ^b   García, Susana ^b   Vay, Carlos ^b   Famiglietti, Angela ^b   Mollerach, Marta ^a  

^a UNIVERSIDAD DE BUENOS AIRES   (Argentina)

^b HOSPITAL DE CLÍNICAS JOSÉ DE SAN MARTÍN   (Argentina)

Author keywords

[No Author keywords available]

Indexed keywords

VANCOMYCIN;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARGENTINA; ARTICLE; BACTERIAL STRAIN; BACTERIUM CULTURE; BACTERIUM DETECTION; BACTERIUM IDENTIFICATION; BACTERIUM ISOLATE; BACTERIUM ISOLATION; BLOOD SAMPLING; CLONE; CONTROLLED STUDY; GENE FREQUENCY; GENETIC CORRELATION; GENETIC TRAIT; HOSPITAL PATIENT; HUMAN; MAJOR CLINICAL STUDY; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; MOLECULAR TYPING; MULTILOCUS SEQUENCE TYPING; NONHUMAN; OBSERVATIONAL STUDY; PHENOTYPE; PREVALENCE; PRIORITY JOURNAL; PROSPECTIVE STUDY; STAPHYLOCOCCAL BACTEREMIA; TEACHING HOSPITAL; VANCOMYCIN INTERMEDIATE STAPHYLOCOCCUS AUREUS; AREA UNDER THE CURVE; BACTEREMIA; BACTERIAL COUNT; DRUG EFFECTS; GENOTYPE; MICROBIOLOGY; MULTIDRUG RESISTANCE; STAPHYLOCOCCAL INFECTIONS; STAPHYLOCOCCUS AUREUS;

METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; STAPHYLOCOCCUS AUREUS;

AREA UNDER CURVE; ARGENTINA; BACTEREMIA; COLONY COUNT, MICROBIAL; DRUG RESISTANCE, MULTIPLE, BACTERIAL; GENOTYPE; HOSPITALS, TEACHING; HUMANS; PROSPECTIVE STUDIES; STAPHYLOCOCCAL INFECTIONS; STAPHYLOCOCCUS AUREUS; VANCOMYCIN RESISTANCE;

EID: 84922496383     PISSN: 10766294     EISSN: 19318448     Source Type: Journal    
DOI: 10.1089/mdr.2014.0190     Document Type: Article

References (50)

1. Bobin-Dubreux, S., M.E. Reverdy, C. Nervi, M. Rougier, A. Bolmstrom, F. Vandenesch, and J. Etienne. 2001. Clinical isolate of vancomycin-heterointermediate Staphylococcus aureus susceptible to methicillin and in vitro selection of a vancomycin-resistant derivative. Antimicrob. Agents Chemother. 45:349-352.
2. Boyen, F., F. Vangroenweghe, P. Butaye, E. De Graef, F. Castryck, P. Heylen, M. Vanrobaeys, and F. Haesebrouck. 2010. Disk prediffusion is a reliable method for testing colistin susceptibility in porcine E. coli strains. Vet. Microbiol. 144:359-362.
3. Campanile, F., D. Bongiorno, M. Falcone, F. Vailati, M.B. Pasticci, M. Perez, A. Raglio, F. Rumpianesi, C. Scuderi, F. Suter, et al. 2012. Changing Italian nosocomialcommunity trends and heteroresistance in Staphylococcus aureus from bacteremia and endocarditis. Eur. J. Clin. Microbiol. Infect. Dis. 31:739-745.
4. Chatterjee, S.S., and M. Otto. 2013. Improved understanding of factors driving methicillin-resistant Staphylococcus aureus epidemic waves. Clin. Epidemiol. 5:205-217.
5. Chung, M., H. de Lencastre, P. Matthews, A. Tomasz, I. Adamsson, M. Aires de Sousa, T. Camou, C. Cocuzza, A. Corso, I. Couto, et al. 2000. Molecular typing of methicillin-resistant Staphylococcus aureus by pulsed-field gel electrophoresis: comparison of results obtained in a multilaboratory effort using identical protocols and MRSA strains. Microb. Drug Resist. 6:189-198.
6. CLSI. 2012. Methods for Dilution Antimicrobial Susceptibility Tests for Bacteria That Grow Aerobically. Approved Standard M7-A7. Clinical and Laboratory Standards Institute, Wayne, PA.
7. Enright, M.C., K. Knox, D. Griffiths, D.W. Crook, and B.G. Spratt. 2000. Molecular typing of bacteria directly from cerebrospinal fluid. Eur. J. Clin. Microbiol. Infect. Dis. 19:627-630.
8. Fernandez, S., L. de Vedia, M.J. Lopez Furst, N. Gardella, S. Di Gregorio, M.C. Ganaha, S. Prieto, E. Carbone, N. Lista, F. Rotrying, et al. 2013. Methicillinresistant Staphylococcus aureus ST30-SCCmec IVc clone as the major cause of community-acquired invasive infections in Argentina. Infect. Genet. Evol. 14:401-405.
9. Gardella, N., S. Fernandez, S. Di Gregorio, A. Cuirolo, G. Gutkind, and M. Mollerach. [Comparative study of clones from isolates methicillin-resistant Staphylococcus aureus prevalent in Argentina]. Rev. Panam. Salud Publica 30:665-666.
10. Gardella, N., S. Fernandez, S.D. Gregorio, A. Cuirolo, G. Gutkind, and M. Mollerach. 2011. Estudio comparativo de los clones de aislamientos de Staphylococcus aureus resistente a meticilina prevalentes en la Argentina. Rev. Panam. Salud Publica 30:665-666.
11. Gardella, N., S. Murzicato, S. Di Gregorio, A. Cuirolo, J. Desse, F. Crudo, G. Gutkind, and M. Mollerach. 2011. Prevalence and characterization of methicillin-resistant Staphylococcus aureus among healthy children in a city of Argentina. Infect. Genet. Evol. 11:1066-1071.
12. Gardella, N., R. Picasso, S.C. Predari, M. Lasala, M. Foccoli, G. Benchetrit, A. Famiglietti, M. Catalano, M. Mollerach, and G. Gutkind. 2005. Methicillin-resistant Staphylococcus aureus strains in Buenos Aires teaching hospitals: replacement of the multidrug resistant South American clone by another susceptible to rifampin, minocycline and trimethoprim-sulfamethoxazole. Rev. Argent. Microbiol. 37:156-160.
13. Gardella, N., M. von Specht, A. Cuirolo, A. Rosato, G. Gutkind, and M. Mollerach. 2008. Community-associated methicillin-resistant Staphylococcus aureus, eastern Argentina. Diagn. Microbiol. Infect. Dis. 62:343-347.
14. Garnier, F., D. Chainier, T. Walsh, A. Karlsson, A. Bolmstrom, C. Grelaud, M. Mounier, F. Denis, and M.C. Ploy. 2006. A 1 year surveillance study of glycopeptide-intermediate Staphylococcus aureus strains in a French hospital. J. Antimicrob. Chemother. 57:146-149.
15. Gilot, P., G. Lina, T. Cochard, and B. Poutrel. 2002. Analysis of the genetic variability of genes encoding the RNA III-activating components Agr and TRAP in a population of Staphylococcus aureus strains isolated from cows with mastitis. J. Clin. Microbiol. 40:4060-4067.
16. Harmsen, D., H. Claus, W. Witte, J. Rothganger, D. Turnwald, and U. Vogel. 2003. Typing of methicillinresistant Staphylococcus aureus in a university hospital setting by using novel software for spa repeat determination and database management. J. Clin. Microbiol. 41:5442-5448.
17. Hiramatsu, K., H. Hanaki, T. Ino, K. Yabuta, T. Oguri, and F.C. Tenover. 1997. Methicillin-resistant Staphylococcus aureus clinical strain with reduced vancomycin susceptibility. J. Antimicrob. Chemother. 40:135-136.
18. Holmes, N.E., P.D. Johnson, and B.P. Howden. 2012. Relationship between vancomycin-resistant Staphylococcus aureus, vancomycin-intermediate S. aureus, high vancomycin MIC, and outcome in serious S. aureus infections. J. Clin. Microbiol. 50:2548-2552.
19. Horne, K.C., B.P. Howden, E.A. Grabsch, M. Graham, P.B. Ward, S. Xie, B.C. Mayall, P.D. Johnson, and M.L. Grayson. 2009. Prospective comparison of the clinical impacts of heterogeneous vancomycin-intermediate methicillin-resistant Staphylococcus aureus (MRSA) and vancomycin-susceptible MRSA. Antimicrob. Agents Chemother. 53:3447-3452.
20. Howden, B.P., J.K. Davies, P.D. Johnson, T.P. Stinear, and M.L. Grayson. 2010. Reduced vancomycin susceptibility in Staphylococcus aureus, including vancomycinintermediate and heterogeneous vancomycin-intermediate strains: resistance mechanisms, laboratory detection, and clinical implications. Clin. Microbiol. Rev. 23:99-139.
21. Howe, R.A., A. Monk, M. Wootton, T.R. Walsh, and M.C. Enright. 2004. Vancomycin susceptibility within methicillin-resistant Staphylococcus aureus lineages. Emerg. Infect. Dis. 10:855-857.
22. Jacob, J.T., and C.A. Diazgranados. 2013. High vancomycin minimum inhibitory concentration and clinical outcomes in adults with methicillin-resistant Staphylococcus aureus infections: a meta-analysis. Int. J. Infect. Dis. 17: e93-e100.
23. Katz, B.D., S.A. Luperchio, and G.M. Thorne. 2008. Detection of daptomycin-nonsusceptible strains using the Neo-Sensitab prediffusion method. Diagn. Microbiol. Infect. Dis. 61:315-320.
24. Kobayashi, S.D., J.M. Musser, and F.R. DeLeo. 2012. Genomic analysis of the emergence of vancomycin-resistant Staphylococcus aureus. MBio 3:e00170-12.
25. Kondo, Y., T. Ito, X.X. Ma, S. Watanabe, B.N. Kreiswirth, J. Etienne, and K. Hiramatsu. 2007. Combination of multiplex PCRs for staphylococcal cassette chromosome mec type assignment: rapid identification system for mec, ccr, and major differences in junkyard regions. Antimicrob. Agents Chemother. 51:264-274.
26. Kosowska-Shick, K., L.M. Ednie, P. McGhee, K. Smith, C.D. Todd, A. Wehler, and P.C. Appelbaum. 2008. Incidence and characteristics of vancomycin nonsusceptible strains of methicillin-resistant Staphylococcus aureus at Hershey Medical Center. Antimicrob. Agents Chemother. 52:4510-4513.
27. Lalueza, A., F. Chaves, R. San Juan, M. Daskalaki, J.R. Otero, and J.M. Aguado. 2010. Is high vancomycin minimum inhibitory concentration a good marker to predict the outcome of methicillin-resistant Staphylococcus aureus bacteremia? J. Infect. Dis. 201:311-312; author reply 312-313.
28. Lattar, S.M., L.P. Tuchscherr, D. Centron, K. Becker, S.C. Predari, F.R. Buzzola, D.A. Robinson, and D.O. Sordelli. 2012. Molecular fingerprinting of Staphylococcus aureus isolated from patients with osteomyelitis in Argentina and clonal distribution of the cap5(8) genes and of other selected virulence genes. Eur. J. Clin. Microbiol. Infect. Dis. 31:2559-2566.
29. Lin, S.Y., T.C. Chen, F.J. Chen, Y.H. Chen, Y.I. Lin, L.K. Siu, and P.L. Lu. 2012. Molecular epidemiology and clinical characteristics of hetero-resistant vancomycin intermediate Staphylococcus aureus bacteremia in a Taiwan Medical Center. J. Microbiol. Immunol. Infect. 45:435-441.
30. Liu, C., A. Bayer, S.E. Cosgrove, R.S. Daum, S.K. Fridkin, R.J. Gorwitz, S.L. Kaplan, A.W. Karchmer, D.P. Levine, B.E. Murray, et al. 2011. Clinical practice guidelines by the infectious diseases society of america for the treatment of methicillin-resistant Staphylococcus aureus infections in adults and children: executive summary. Clin. Infect. Dis. 52:285-292.
31. Lopez Furst, M.J., L. de Vedia, S. Fernandez, N. Gardella, M.C. Ganaha, S. Prieto, E. Carbone, N. Lista, F. Rotryng, G.I. Morera, et al. 2013. Prospective multicenter study of community-associated skin and skin structure infections due to methicillin-resistant Staphylococcus aureus in Buenos Aires, Argentina. PLoS One 8:e78303.
32. Nielsen, S.V., and J.B. Casals. 2005. Detection of decreased susceptibility to glycopeptides in S. aureus using tablet (disc) prediffusion. In 15th European Congress of Clinical Microbiology and Infectious Diseases Copenhagen/ Denmark, April 2-5, 2005.
33. Oliveira, D.C., and H. de Lencastre. 2002. Multiplex PCR strategy for rapid identification of structural types and variants of the mec element in methicillin-resistant Staphylococcus aureus. Antimicrob. Agents Chemother. 46:2155-2161.
34. Park, K.H., E.S. Kim, H.S. Kim, S.J. Park, K.M. Bang, H.J. Park, S.Y. Park, S.M. Moon, Y.P. Chong, S.H. Kim, et al. 2012. Comparison of the clinical features, bacterial genotypes and outcomes of patients with bacteraemia due to heteroresistant vancomycin-intermediate Staphylococcus aureus and vancomycin-susceptible S. aureus. J. Antimicrob. Chemother. 67:1843-1849.
35. Perazzi, B., N. Bello, M. Mollerach, C. Vay, M.B. Lasala, and A. Famiglietti. 2011. Endocarditis caused by methicillin-susceptible Staphylococcus aureus with reduced susceptibility to vancomycin: a case report. J. Med. Case Rep. 5:555.
36. Prakash, V., J.S. Lewis, 2nd, and J.H. Jorgensen. 2008. Vancomycin MICs for methicillin-resistant Staphylococcus aureus isolates differ based upon the susceptibility test method used. Antimicrob. Agents Chemother. 52:4528.
37. Rojas, L., E. Bunsow, P. Munoz, E. Cercenado, M. Rodriguez-Creixems, and E. Bouza. 2012. Vancomycin MICs do not predict the outcome of methicillin-resistant Staphylococcus aureus bloodstream infections in correctly treated patients. J. Antimicrob. Chemother. 67:1760-1768.
38. Rosco Diagnostica A/S T.D. 2010. Neo-Sensitabs-. User s Guide. Susceptibility testing EUCAST and CLSI potency Neo-Sensitabs-. Document 1.5.0. Prediffussion Method.
39. Sader, H.S., P.R. Rhomberg, and R.N. Jones. 2009. Nine-hospital study comparing broth microdilution and Etest method results for vancomycin and daptomycin against methicillin-resistant Staphylococcus aureus. Antimicrob. Agents Chemother. 53:3162-3165.
40. Schweizer, M.L., J.P. Furuno, G. Sakoulas, J.K. Johnson, A.D. Harris, M.D. Shardell, J.C. McGregor, K.A. Thom, and E.N. Perencevich. 2011. Increased mortality with accessory gene regulator (agr) dysfunction in Staphylococcus aureus among bacteremic patients. Antimicrob. Agents Chemother. 55:1082-1087.
41. Sola, C., G. Gribaudo, A. Vindel, L. Patrito, and J.L. Bocco. 2002. Identification of a novel methicillin-resistant Staphylococcus aureus epidemic clone in Cordoba, Argentina, involved in nosocomial infections. J. Clin. Microbiol. 40:1427-1435.
42. Sola, C., R.O. Lamberghini, M. Ciarlantini, A.L. Egea, P. Gonzalez, E.G. Diaz, V. Huerta, J. Gonzalez, A. Corso, M. Vilaro, et al. 2011. Heterogeneous vancomycinintermediate susceptibility in a community-associated methicillin-resistant Staphylococcus aureus epidemic clone, in a case of Infective Endocarditis in Argentina. Ann. Clin. Microbiol. Antimicrob. 10:15.
43. Sola, C., H. Paganini, A.L. Egea, A.J. Moyano, A. Garnero, I. Kevric, C. Culasso, A. Vindel, H. Lopardo, and J.L. Bocco. 2012. Spread of epidemic MRSA-ST5-IV clone encoding PVL as a major cause of community onset Staphylococcal infections in Argentinean children. PLoS One 7:e30487.
44. Soriano, A., F. Marco, J.A. Martinez, E. Pisos, M. Almela, V.P. Dimova, D. Alamo, M. Ortega, J. Lopez, and J. Mensa. 2008. Influence of vancomycin minimum inhibitory concentration on the treatment of methicillinresistant Staphylococcus aureus bacteremia. Clin. Infect. Dis. 46:193-200.
45. Takesue, Y., K. Nakajima, Y. Takahashi, K. Ichiki, M. Ishihara, Y. Wada, T. Tsuchida, M. Uchino, and H. Ikeuchi. 2011. Clinical characteristics of vancomycin minimum inhibitory concentration of 2 mg/ml methicillinresistant Staphylococcus aureus strains isolated from patients with bacteremia. J. Infect. Chemother. 17:52-57.
46. van Hal, S.J., M.C. Wehrhahn, T. Barbagiannakos, J. Mercer, D. Chen, D.L. Paterson, and I.B. Gosbell. 2011. Performance of various testing methodologies for detection of heteroresistant vancomycin-intermediate Staphylococcus aureus in bloodstream isolates. J. Clin. Microbiol. 49: 1489-1494.
47. von Specht, M., N. Gardella, P. Tagliaferri, G. Gutkind, and M. Mollerach. 2006. Methicillin-resistant Staphylococcus aureus in community-acquired meningitis. Eur. J. Clin. Microbiol. Infect. Dis. 25:267-269.
48. Wang, J.L., J.T. Wang, W.H. Sheng, Y.C. Chen, and S.C. Chang. 2010. Nosocomial methicillin-resistant Staphylococcus aureus (MRSA) bacteremia in Taiwan: mortality analyses and the impact of vancomycin, MIC = 2 mg/L, by the broth microdilution method. BMC Infect. Dis. 10:159.
49. Wootton, M., R.A. Howe, R. Hillman, T.R. Walsh, P.M. Bennett, and A.P. MacGowan. 2001. A modified population analysis profile (PAP) method to detect heteroresistance to vancomycin in Staphylococcus aureus in a UK hospital. J. Antimicrob. Chemother. 47:399-403.
50. Yamakawa, J., M. Aminaka, K. Okuzumi, H. Kobayashi, Y. Katayama, S. Kondo, A. Nakamura, T. Oguri, S. Hori, L. Cui, et al. 2012. Heterogeneously vancomycinintermediate Staphylococcus aureus (hVISA) emerged before the clinical introduction of vancomycin in Japan: a retrospective study. J. Infect. Chemother. 18:406-409.